Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases

Autor: Famke L. Schneiders, Berend J. Slotman, Suresh Senan, A. Bruynzeel, Miguel A. Palacios, John R. van Sörnsen de Koste, Claire C van Vliet
Přispěvatelé: Radiation Oncology, CCA - Cancer Treatment and quality of life
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: van Sörnsen de Koste, J R, van Vliet, C C, Schneiders, F L, Bruynzeel, A M E, Slotman, B J, Palacios, M A & Senan, S 2021, ' Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases ', Physics and Imaging in Radiation Oncology, vol. 20, pp. 1-4 . https://doi.org/10.1016/j.phro.2021.09.001, https://doi.org/10.1016/j.phro.2021.09.001
Physics and Imaging in Radiation Oncology, Vol 20, Iss, Pp 1-4 (2021)
Physics and Imaging in Radiation Oncology, 20, 1-4. Elsevier Ireland Ltd
Physics and Imaging in Radiation Oncology
ISSN: 2405-6316
DOI: 10.1016/j.phro.2021.09.001
Popis: Stereotactic ablative radiotherapy (SABR) planning for adrenal metastases aims to minimize doses to the adjacent kidney. Renal dose constraints for SABR delivery are not well defined. In 20 patients who underwent MR-guided breath-hold SABR in five daily fractions of 8–10 Gy, ipsilateral renal volumes receiving ≥20 Gy best correlated with loss of renal volumes, with median renal volume reduction being 6% (range: 3%-11%, 10th-90th percentiles). Organ function did not deteriorate in 18 patients, who had post treatment renal function tests available. This suggests that the ipsilateral renal volume receiving 20 Gy can be used as partial organ dose constraint for SABR to targets in the upper abdomen.
Databáze: OpenAIRE